Institute of Hematology & Blood Diseases Hospital, Tianjin
The Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS), is a public Grade 3A specialist hospital in Tianjin, China. Founded in 1957, it provides adult and paediatric haematology services, including care for leukaemia, lymphoma, multiple myeloma, anaemia and bleeding disorders. Its International Medical Center at the Tuanbo campus provides a dedicated contact route for overseas enquiries.
Hospital at a Glance
-
Chinese name: 中国医学科学院血液病医院（中国医学科学院血液学研究所）
-
Hospital type: Public Grade III, Class A (3A) specialist blood diseases hospital
-
Affiliation: Chinese Academy of Medical Sciences and Peking Union Medical College
-
Founded: 1957
-
Location: Tianjin, China; Haiguangsi, Tuanbo and Huayuan campuses
-
Main clinical areas: Adult and paediatric haematology, blood cancers, bone marrow failure, bleeding disorders and haematopoietic stem cell transplantation
-
International care enquiry: International Medical Center (国际诊疗中心), Tuanbo campus, Building 1, Floor 4
This profile introduces the hospital’s main haematology centres and practical arrangements for an overseas visit to Tianjin. For a specialist consultation, pathology review, transplant or CAR-T enquiry, a concise diagnosis and treatment history helps the receiving team direct your request to the relevant service.
Key Specialties & Departments
Leukaemia — 白血病
The Leukaemia Center treats adult acute myeloid leukaemia (AML), acute lymphoblastic leukaemia (ALL), chronic myeloid leukaemia (CML) and chronic lymphocytic leukaemia (CLL). Its specialists work on diagnosis and targeted treatment of acute leukaemia. An enquiry can focus on a new diagnosis, a review of previous treatment or care after relapse.
Lymphoma and Multiple Myeloma — 淋巴瘤与多发性骨髓瘤
The Lymphoma and Myeloma Center covers Hodgkin and non-Hodgkin lymphoma, multiple myeloma, CLL and other clonal lymphoproliferative disorders. Its clinical and research work includes molecular characterisation, targeted therapies and haematopoietic stem cell transplantation. Existing pathology, imaging and treatment records provide a useful starting point for a consultation enquiry.
Haematopoietic Stem Cell Transplantation — 造血干细胞移植
The Stem Cell Transplantation Center provides autologous, allogeneic and haploidentical transplantation for blood diseases. Its clinical expertise also includes transplant-related complications and infections in patients with weakened immune systems. For a transplant assessment, include previous treatment, any earlier transplant records and available HLA typing or donor information in the initial enquiry.
MDS and Myeloproliferative Neoplasms — 骨髓增生异常综合征与骨髓增殖性肿瘤
The MDS/MPN Center focuses on myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN) and related myeloid disorders. Specialist areas include myelofibrosis, polycythaemia vera and essential thrombocythaemia. Bone marrow findings, chromosome analysis, molecular test results and previous blood counts are useful records to discuss with the receiving service.
Paediatric Haematology and Oncology — 儿童血液与肿瘤
The Paediatric Haematology and Oncology Center treats childhood leukaemia, bone marrow failure syndromes and rare or complex blood disorders. Its published scope includes Fanconi anaemia, Diamond–Blackfan anaemia, childhood MDS and juvenile myelomonocytic leukaemia. Families can enquire about the relevant paediatric specialist, records required for assessment and arrangements for an accompanying parent or guardian.
Anaemia and Bone Marrow Failure — 贫血与骨髓衰竭
The Red Blood Cell Disorder Center treats different forms of anaemia, with a particular focus on severe aplastic anaemia. Its specialists also cover haemolytic disorders, pure red cell aplasia and selected inherited or rare conditions. A consultation enquiry can include the blood count history, bone marrow reports, transfusion history and details of previous treatment.
Bleeding, Platelet and Thrombotic Disorders — 出血、血小板与血栓性疾病
The Thrombosis and Haemostasis Center covers inherited and acquired bleeding and thrombotic disorders. Published specialist areas include haemophilia, immune thrombocytopenia (ITP), platelet function disorders and coagulation factor deficiencies. For an enquiry, provide the diagnosis, bleeding or clotting history, relevant laboratory results and current medication details.
Cellular Therapies and Clinical Research — 细胞治疗与临床研究
The Immune Cellular Therapy Center works on cellular immunotherapy, molecular targeted therapy and combination treatment for leukaemia. The International Medical Center also lists CAR-T therapy, haematopoietic stem cell transplantation and gene therapy within its clinical scope. The hospital’s GCP centre conducts early-phase studies of new haematology medicines. For a specific therapy enquiry, ask for the product or study name, treatment indication, assessment process and planned monitoring.
Haematopathology and Molecular Diagnostics — 血液病理与分子诊断
The Haematopathology Diagnostic Center combines tissue pathology, blood and bone marrow cell morphology, flow cytometry, cytogenetics and molecular testing. It also provides pathology consultation on material from other hospitals. The hospital’s published review guide asks for the original pathology report, stained slides and relevant clinical records, with unstained sections or tissue blocks submitted where needed.
Services for International Patients
International Medical Center
-
The International Medical Center (国际诊疗中心) opened in August 2025 and brings together specialists from the hospital’s clinical centres. Its published services include appointment coordination, patient escort and coordination of investigations and results.
-
Published ward location: Tuanbo campus, Building 1, Floor 4. International Medical Center telephone: +86 22 2360 8099. Email: patientservice@ihcams.ac.cn.
-
For an overseas enquiry, send a short case summary, the service you are seeking and your preferred dates. Request the record-submission process, receiving specialist, passport registration steps and outpatient or admission arrangements.
Appointments & Campus Locations
-
Haiguangsi campus — 海光寺院区: No. 288 Nanjing Road, Heping District, Tianjin, China. Chinese address: 天津市和平区南京路288号.
-
Tuanbo campus — 团泊院区: No. 28 Tuanbo Avenue, Jinghai District, Tianjin, China. Chinese address: 天津市静海区团泊大道28号. The International Medical Center is located at this campus.
-
The hospital also lists a Huayuan campus in Xiqing District. Obtain the receiving campus, building, department and check-in time with your appointment confirmation, then use that location for transport and accommodation planning.
-
General medical service telephone: +86 22 2390 9083. For first-time registration, ask how your foreign passport details will be entered and which booking route to use. Keep your name and identity details consistent across the booking and medical records.
Documents to Prepare
-
Your original passport, appointment confirmation and any registration documents requested by the department. For a child, ask which identity and guardianship documents are needed.
-
A concise diagnosis and treatment timeline, consultation notes, discharge summaries, recent blood counts and other relevant laboratory results.
-
Bone marrow and tissue pathology reports, flow cytometry, chromosome or FISH results, molecular and genetic test reports, and relevant imaging reports with DICOM files where available.
-
Previous chemotherapy, targeted therapy or immunotherapy names and dates, transfusion history, any transplant or CAR-T treatment summary, and available HLA typing or donor information for a transplant enquiry.
-
A current medication list, known allergies and insurance details. Ask which records need translation and how the receiving team would like the documents organised.
Pathology Review & Material Handling
The hospital’s pathology consultation guide places this service at the Tuanbo campus, outpatient building, Floor 3, Room 3-005. Its published routine report timeframe is 5–7 working days, with additional time for complex cases or further tests. Pathology enquiries: +86 22 2360 8269 during weekday working hours.
Before borrowing slides or blocks from your original hospital, obtain the receiving team’s material list and submission instructions. Keep patient identifiers consistent on the reports and specimens, retain copies of documents, and agree how borrowed material will be collected and returned.
Consultation Language & Medical Reports
-
Include your preferred consultation language in the initial enquiry. Ask about the doctor’s consultation language and interpretation for consultations, investigations, consent discussions and admission paperwork.
-
Request details of which reports can be issued in English, how translation is arranged and any related charges. Include pathology, molecular results, imaging files and the discharge summary in your document request.
-
Agree how remaining results will be delivered and obtain the department’s contact route for further appointments or report queries after you return home.
Fees, Payment & Insurance
-
Request an itemised estimate for the planned consultation, diagnostic work or hospital stay. For a transplant or cellular therapy enquiry, ask about assessment tests, medication or cell product, collection and processing, admission, monitoring and follow-up charges.
-
Ask the receiving unit about deposits, payment currency and accepted payment methods, including an overseas-issued bank card. Request separate details for any coordination, translation or interpretation fees.
-
The International Medical Center refers to international payment and insurance options. Send your insurer and policy details and request confirmation of pre-authorisation, direct settlement and reimbursement documents for the proposed service.
Visit Length & Follow-up
-
Ask for the expected sequence of specialist assessment, pathology review, tests and any admission before choosing travel dates. Include time for outstanding results and additional appointments in your stay planning.
-
For transplantation or CAR-T enquiries, request the anticipated inpatient period, local monitoring schedule, caregiver arrangements and accommodation needs. Discuss travel timing and plans for continuing care with the hospital team.
-
Before departure, collect the available reports, treatment summary and written follow-up plan. Arrange how records and any remaining results will reach the clinician continuing your care at home.
Hospital Background and Haematology Research
Founded in 1957, the Institute of Hematology & Blood Diseases Hospital is part of the Chinese Academy of Medical Sciences and Peking Union Medical College. It combines specialist clinical care with laboratory research, medical education and the development of new approaches to blood disease diagnosis and treatment.
The hospital is a base for the National Clinical Research Center for Blood Diseases. Its clinical services are organised around disease-specific centres, supported by haematopathology and laboratory diagnostics, transplant services, intensive care and clinical research.
The hospital lists Haiguangsi, Tuanbo and Huayuan campuses in Tianjin. The International Medical Center is at the Tuanbo campus, where it provides a dedicated service route for domestic and overseas patients.
Planning an International Patient Visit to Tianjin
A useful first enquiry explains the diagnosis, previous treatment and the question you would like to discuss, such as a specialist consultation, pathology review, transplant assessment or cellular therapy enquiry. Include the patient’s age, country of residence, language needs and preferred dates, then request the hospital’s instructions for submitting medical records.
Agree the receiving specialist and campus, registration process, expected sequence of visits and cost estimate before arranging your stay. For a longer admission, include caregiver accommodation, local follow-up and the records needed by your doctor at home in the planning discussion.
How MedBridgeNZ Can Help
MedBridgeNZ provides medical concierge and logistics coordination for international patients planning a haematology-related hospital visit in Tianjin. We can assist with medical record translation, hospital and specialist communication, appointment coordination, interpretation, visit accompaniment and relevant travel arrangements.
Share your main diagnosis, treatment history, the service you are enquiring about and your preferred dates. We can help organise your enquiry to the Institute of Hematology & Blood Diseases Hospital and clarify the documents, receiving campus, language support and practical steps for your visit.
Frequently Asked Questions
Is the Institute of Hematology & Blood Diseases Hospital a public hospital?
Yes. It is a public Grade III, Class A (3A) specialist blood diseases hospital in Tianjin, associated with the Chinese Academy of Medical Sciences and Peking Union Medical College. It was founded in 1957.
Which blood diseases does the hospital treat?
Its centres cover adult and childhood leukaemia, lymphoma, multiple myeloma, MDS, myeloproliferative neoplasms, aplastic anaemia and other red blood cell disorders, haemophilia, platelet conditions and thrombotic disorders. It also has dedicated transplantation, cellular therapy and haematopathology services.
How can international patients enquire about an appointment?
Contact the International Medical Center on +86 22 2360 8099 or email patientservice@ihcams.ac.cn. Include a brief diagnosis and treatment history, the service you are seeking, language needs and preferred dates. Ask for the medical record submission and foreign-passport registration process.
Which campus houses the International Medical Center?
The hospital’s Chinese department page lists the International Medical Center at the Tuanbo campus, Building 1, Floor 4, at No. 28 Tuanbo Avenue, Jinghai District, Tianjin. The Haiguangsi campus is at No. 288 Nanjing Road, Heping District. Use the campus and clinic specified in your appointment confirmation.
Does the hospital provide CAR-T therapy and stem cell transplantation?
The hospital lists CAR-T therapy and haematopoietic stem cell transplantation within its clinical services. Its transplant centre provides autologous, allogeneic and haploidentical transplantation. For a specific enquiry, send your diagnosis and previous treatment records and request the assessment process, proposed product or treatment, expected schedule and itemised estimate.
Can I arrange a review of pathology from another hospital?
The hospital provides pathology consultation on outside material. Its guide lists pathology reports, stained slides and relevant clinical records, with unstained sections or tissue blocks included where needed. Routine reports are listed at 5–7 working days, with longer timeframes for complex cases or additional testing. Obtain submission and material-return instructions before arranging the review.
Can I arrange an English-language consultation and English reports?
Include your language needs when contacting the hospital. Ask about the doctor’s consultation language, interpretation arrangements, which records can be issued in English and how translation and related fees are handled. Agree how reports and any remaining results will reach you after the visit.
How much will care cost, and can I use international insurance?
Request an itemised estimate for your planned consultation, tests or admission. Send your policy details to the hospital and insurer and ask about pre-authorisation, direct settlement, deposits, overseas-card payments and documents for reimbursement. For transplantation or CAR-T, include assessment, the treatment or product, hospital care and follow-up in the estimate request.
Disclaimer:
Information on this page is based on the hospital’s official English and Chinese websites, department descriptions, contact information and pathology consultation guidance, together with Tianjin government hospital information. Services, locations, schedules, fees, language support, payment and insurance arrangements may change; confirm current details with the receiving hospital unit.
This page provides general information. Hospital clinicians assess suitability and make decisions about investigations, diagnosis, treatment and follow-up. Access to a specific medicine, cellular or gene therapy, transplant or clinical trial depends on the diagnosis, applicable regulatory or study requirements and the hospital’s assessment. MedBridgeNZ provides medical concierge and logistics coordination and does not provide medical advice, diagnosis or treatment. Appointment availability, hospital acceptance, study enrolment and treatment outcomes are not guaranteed.